138 related articles for article (PubMed ID: 23036582)
1. CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer.
Wang D; Zhu H; Zhu Y; Liu Y; Shen H; Yin R; Zhang Z; Su Z
Acta Histochem; 2013 May; 115(4):349-56. PubMed ID: 23036582
[TBL] [Abstract][Full Text] [Related]
2. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.
Hong SP; Wen J; Bang S; Park S; Song SY
Int J Cancer; 2009 Nov; 125(10):2323-31. PubMed ID: 19598259
[TBL] [Abstract][Full Text] [Related]
3. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
[TBL] [Abstract][Full Text] [Related]
5. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.
Park SH; Sung JH; Chung N
Mol Cell Biochem; 2014 Sep; 394(1-2):209-15. PubMed ID: 24894821
[TBL] [Abstract][Full Text] [Related]
6. Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells.
Tang ZY; Wu YL; Gao SL; Shen HW
J Surg Res; 2008 Mar; 145(1):111-23. PubMed ID: 17714734
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH
Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition.
Quint K; Tonigold M; Di Fazio P; Montalbano R; Lingelbach S; Rückert F; Alinger B; Ocker M; Neureiter D
Int J Oncol; 2012 Dec; 41(6):2093-102. PubMed ID: 23026911
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a pancreatic cancer stem cell model using the SW1990 human pancreatic cancer cell line in nude mice.
Pan Y; Gao S; Hua YQ; Liu LM
Asian Pac J Cancer Prev; 2015; 16(2):437-42. PubMed ID: 25684468
[TBL] [Abstract][Full Text] [Related]
11. Effects of ER-resident and secreted AGR2 on cell proliferation, migration, invasion, and survival in PANC-1 pancreatic cancer cells.
Hong X; Li ZX; Hou J; Zhang HY; Zhang CY; Zhang J; Sun H; Pang LH; Wang T; Deng ZH
BMC Cancer; 2021 Jan; 21(1):33. PubMed ID: 33413231
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells.
Lu Y; Zhu H; Shan H; Lu J; Chang X; Li X; Lu J; Fan X; Zhu S; Wang Y; Guo Q; Wang L; Huang Y; Zhu M; Wang Z
Cancer Lett; 2013 Oct; 340(1):113-23. PubMed ID: 23872274
[TBL] [Abstract][Full Text] [Related]
13. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
[TBL] [Abstract][Full Text] [Related]
14. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
[TBL] [Abstract][Full Text] [Related]
15. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells.
Yao J; Cai HH; Wei JS; An Y; Ji ZL; Lu ZP; Wu JL; Chen P; Jiang KR; Dai CC; Qian ZY; Xu ZK; Miao Y
Oncol Rep; 2010 May; 23(5):1375-82. PubMed ID: 20372854
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
Hu G; Li F; Ouyang K; Xie F; Tang X; Wang K; Han S; Jiang Z; Zhu M; Wen D; Qin X; Zhang L
Int J Oncol; 2012 Mar; 40(3):798-806. PubMed ID: 22076649
[TBL] [Abstract][Full Text] [Related]
17. Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells.
Huang CC; Lin CM; Huang YJ; Wei L; Ting LL; Kuo CC; Hsu C; Chiou JF; Wu ATH; Lee WH
Biotechnol Appl Biochem; 2017 Mar; 64(2):165-173. PubMed ID: 26400206
[TBL] [Abstract][Full Text] [Related]
18. [A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM].
Yuan W; Sui CG; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):330-334. PubMed ID: 29860758
[No Abstract] [Full Text] [Related]
19. Persistence of side population cells with high drug efflux capacity in pancreatic cancer.
Zhou J; Wang CY; Liu T; Wu B; Zhou F; Xiong JX; Wu HS; Tao J; Zhao G; Yang M; Gou SM
World J Gastroenterol; 2008 Feb; 14(6):925-30. PubMed ID: 18240351
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine.
Yin T; Wei H; Gou S; Shi P; Yang Z; Zhao G; Wang C
Int J Mol Sci; 2011; 12(3):1595-604. PubMed ID: 21673909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]